Skip to main content

Evidence that pretransplant donor blood transfusion prevents rat renal allograft dysfunction but not the in situ cellular alloimmune or morphologic manifestations of rejection.

Publication ,  Journal Article
Ruiz, P; Coffman, TM; Howell, DN; Straznickas, J; Scroggs, MW; Baldwin, WM; Klotman, PE; Sanfilippo, F
Published in: Transplantation
January 1988

The effects of preoperative donor-specific blood transfusion (DSBT) on the physiologic, morphologic, and immunologic aspects of allograft responsiveness were evaluated in a rat renal transplant model, using the ACI (RT1a) into PVG (RT1c) high-responder strain combination. Indefinite graft survival (mean greater than 63 days) could be induced by DSBT administration alone. In comparison, animals receiving autologous blood transfusion (ABT) all died within 7 days posttransplantation. As assessed by clearance of inulin and paraaminohippurate, renal allograft function in DSBT-pretreated recipients at 6 days was equivalent to that of isograft recipients, and in contrast to the significant reduction seen in ABT treated rats. Likewise, thromboxane B2 (TXB2) production by ex-vivo-perfused allografts from DSBT-treated recipients was comparable to that of isografts, and significantly lower than that of allografts from ABT-treated rats. A significant inverse correlation was found between renal TXB2 production and inulin clearance. Despite these substantial differences in renal function and eicosanoid metabolism, morphologic evaluation of renal allografts from DSBT-enhanced and ABT-rejecting recipients at comparable time points showed equivalent histologic manifestations of rejection. In addition, immunohistologic labeling of renal allograft sections and fluorescence-activated cell sorter analysis of cells eluted from allografts showed the same phenotype and pattern of infiltrating T cell subsets in both groups. Specific antidonor cytotoxic T lymphocyte precursor (pCTL) frequencies of cells eluted from kidney grafts were equivalent in DSBT and ABT-pretreated animals, and both groups expressed significantly higher (but equivalent) pCTL frequencies in the kidneys than spleens. Comparisons of the lysis of PVG.R1 (RT1.Aa on a PVG background) and ACI targets indicated that cytotoxic responses from effector cells freshly eluted from DSBT and ABT kidneys were primarily directed against allogeneic class I major histocompatibility complex (MHC) specificities, whereas several long term T cell lines generated from 6-day kidney transplants of both groups expressed a predominant W3/25+ (T helper) phenotype and cytotoxic activity against donor specificities other than RT1.Aa class I MHC. Specific antidonor proliferative T lymphocyte (pPTL) precursor frequencies of cells eluted from renal allografts were also equivalent for both DSBT- and ABT-treated recipients, and the range of pPTL frequencies for allograft cell eluates was similar to that in spleens, regardless of the source of the transfusion.(ABSTRACT TRUNCATED AT 400 WORDS)

Duke Scholars

Published In

Transplantation

DOI

ISSN

0041-1337

Publication Date

January 1988

Volume

45

Issue

1

Start / End Page

1 / 7

Location

United States

Related Subject Headings

  • Transplantation, Homologous
  • Thromboxane B2
  • T-Lymphocytes, Cytotoxic
  • Surgery
  • Rats, Inbred Strains
  • Rats, Inbred ACI
  • Rats
  • Preoperative Care
  • Male
  • Kidney Transplantation
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ruiz, P., Coffman, T. M., Howell, D. N., Straznickas, J., Scroggs, M. W., Baldwin, W. M., … Sanfilippo, F. (1988). Evidence that pretransplant donor blood transfusion prevents rat renal allograft dysfunction but not the in situ cellular alloimmune or morphologic manifestations of rejection. Transplantation, 45(1), 1–7. https://doi.org/10.1097/00007890-198801000-00002
Ruiz, P., T. M. Coffman, D. N. Howell, J. Straznickas, M. W. Scroggs, W. M. Baldwin, P. E. Klotman, and F. Sanfilippo. “Evidence that pretransplant donor blood transfusion prevents rat renal allograft dysfunction but not the in situ cellular alloimmune or morphologic manifestations of rejection.Transplantation 45, no. 1 (January 1988): 1–7. https://doi.org/10.1097/00007890-198801000-00002.
Ruiz, P., et al. “Evidence that pretransplant donor blood transfusion prevents rat renal allograft dysfunction but not the in situ cellular alloimmune or morphologic manifestations of rejection.Transplantation, vol. 45, no. 1, Jan. 1988, pp. 1–7. Pubmed, doi:10.1097/00007890-198801000-00002.
Ruiz P, Coffman TM, Howell DN, Straznickas J, Scroggs MW, Baldwin WM, Klotman PE, Sanfilippo F. Evidence that pretransplant donor blood transfusion prevents rat renal allograft dysfunction but not the in situ cellular alloimmune or morphologic manifestations of rejection. Transplantation. 1988 Jan;45(1):1–7.

Published In

Transplantation

DOI

ISSN

0041-1337

Publication Date

January 1988

Volume

45

Issue

1

Start / End Page

1 / 7

Location

United States

Related Subject Headings

  • Transplantation, Homologous
  • Thromboxane B2
  • T-Lymphocytes, Cytotoxic
  • Surgery
  • Rats, Inbred Strains
  • Rats, Inbred ACI
  • Rats
  • Preoperative Care
  • Male
  • Kidney Transplantation